14 Leaders Recognized for Charting a Path for the Biotech Industry’s LGBTQ+ Community
DURHAM, NC, July 11, 2024 – CREO announced today that its CEO and Co-Founder, Susan Acker-Walsh, has been named a 2024 LGBTQ+ Leader in BioPharma by Endpoints News. The third annual feature recognizes biopharmaceutical leaders chosen from an outpouring of nominations for their inspiring work in making the industry more welcoming for the LGBTQ+ community.
“I am truly humbled to be recognized by Endpoints News as an LGBTQ+ Leader in BioPharma,” said Susan Acker-Walsh, CEO and co-founder of CREO. “The culture of our company – steeped in values like “be kind,” “put people first,” and “create impact” – drive the work we do with our clients to create a better, healthier world. Our team members embody those values every day, and inclusivity is such a vital part of that future.”
CREO is an award-winning provider of management consulting services to growing life sciences, healthcare, and private equity organizations. Founded in 2015, CREO has garnered strong recognition and has been repeatedly named to prestigious lists such as the Inc. 5000 as one of America’s fastest-growing companies. With a strategic recapitalization from Grant Avenue Capital in August 2023, CREO is accelerating its growth journey and industry impact. Both CREO’s co-founders, Susan Acker-Walsh and Mike Townley, have previously been recognized for their contributions to the life sciences industry.
The multifaceted group of LGBTQ+ Leaders in BioPharma honored by Endpoints News includes 14 individuals who are propelling the industry and its new medicines forward. They span companies ranging in size from 10 to 10,000+ employees and include representatives from industry leaders such as Merck, Johnson & Johnson, and Bristol Myers-Squibb.
About CREO
CREO is the preferred consultancy to the world’s most promising life sciences and healthcare companies that seek to improve human health. We serve growing life sciences, healthcare, and private equity portfolio companies across the U.S. and international markets. Our expertise and knowledge in strategy, M&A, commercialization, digital transformation, cybersecurity, analytics, and quality & regulatory compliance help organizations improve today’s business performance and develop tomorrow’s clinical innovations. Founded in 2015, CREO is headquartered in North Carolina’s Research Triangle Park. Join us and together let’s make a meaningful difference. Get in touch or visit our website at www.creoconsulting.com.
